Venous Thromboembolism
📧 Sign up to get email alerts when something new happens for Venous Thromboembolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-09-26Clinical Trial Update: Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy [Phase 4]
Phase 4 trial assessing aspirin for prevention of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy has c…
-
CLINICAL_TRIALS trial_result · 2022-09-08Clinical Trial Update: A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis [NA]
Clinical trial evaluating preventive dosing of fondaparinux vs placebo for preventing venous thromboembolism in patients undergoing coronary…
-
CLINICAL_TRIALS trial_result · 2022-08-25Clinical Trial Update: Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial studied rivaroxaban plus aspirin to manage recurrent venous thromboembolism, including venous thromboses an…
-
FDA approval · 2022-08-23FDA Approved: WARFARIN SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for Warfarin sodium submitted by Amneal Pharmaceuticals LLC.
-
FDA approval · 2022-07-28FDA Approved: ENOXAPARIN SODIUM — Supplemental Application (Gland Pharma Limited)
FDA approved a supplemental application for enoxaparin sodium from Gland Pharma Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-07-05Clinical Trial Update: The SYMPTOMS - SYstematic Elderly Medical Patients Thromboprophylaxis: Efficacy on Symptomatic OutcoMeS - Study [Phase 3]
Phase 3 clinical trial investigating thromboprophylaxis in elderly medical patients for venous thromboembolism; study completed.
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Europe
This is a real-world clinical trial update on edoxaban use for venous thromboembolism in Europe. The results were posted in May 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: A Study to Evaluate Dimolegin in Prevention of Thromboembolic Complications During Knee Replacement [Phase 2]
Phase 2 clinical trial evaluating Dimolegin for prevention of thromboembolic complications during knee replacement is ongoing, with unknown …
-
CLINICAL_TRIALS trial_result · 2022-04-22Clinical Trial Update: Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery [Phase 4]
Phase 4 clinical trial assessing adherence improvements with extended venous thromboembolism prophylaxis after major cancer surgery.
-
CLINICAL_TRIALS trial_result · 2022-04-11Clinical Trial Update: Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients [Phase 3]
Phase 3 trial assessing safety of fondaparinux for routine VTE prophylaxis in medical ICU patients; study terminated.
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial [Phase 3]
Phase 3 trial update on extended prophylaxis with rivaroxaban in medically ill hospitalized COVID-19 patients to prevent thrombosis (MICHELL…
-
CLINICAL_TRIALS trial_result · 2022-03-21Clinical Trial Update: A Study on the Impact of Rabeprazole-induced Elevated Stomach pH on APO-Dabigatran Exposure in Healthy Volunteers [Phase 4]
Phase 4 trial examining how rabeprazole-induced higher stomach pH affects APO-dabigatran exposure in healthy volunteers.
-
FDA approval · 2022-02-15FDA Approved: HEPARIN SODIUM — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for Heparin Sodium submitted by Sandoz Inc., indicating an additional regulatory action on this gene…
-
FDA approval · 2022-01-12FDA Approved: HEPARIN SODIUM — Supplemental Application (Sagent Pharmaceuticals)
FDA approved a supplemental application for HEPARIN SODIUM from Sagent Pharmaceuticals, authorizing changes under an approved supplemental f…
-
FDA approval · 2022-01-12FDA Approved: HEPARIN SODIUM — Supplemental Application (Sagent Pharmaceuticals)
FDA approved a supplemental application for Heparin Sodium from Sagent Pharmaceuticals, confirming regulatory status and updates related to …
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19 [Phase 3]
A Phase 3 trial evaluating Dimolegin (DD217) for prevention of thrombotic complications in hospitalized COVID-19 patients has completed enro…
-
CLINICAL_TRIALS trial_result · 2021-12-09Clinical Trial Update: Screening for Cancer in Patients With Unprovoked VTE [Phase 4]
Phase 4 trial update focused on screening for cancer in patients with unprovoked venous thromboembolism.
-
CLINICAL_TRIALS trial_result · 2021-10-26Clinical Trial Update: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic [Phase 3]
A Phase 3 pragmatic randomized trial compared therapeutic anticoagulation to standard care for COVID-19, completed.
-
CLINICAL_TRIALS trial_result · 2021-10-25Clinical Trial Update: Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma Patients [Phase 4]
Phase 4 trial evaluating prevention of venous thromboembolism in high-risk trauma patients; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-15Clinical Trial Update: Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH Dose [Phase 3]
A Phase 3 pilot feasibility and safety trial evaluating weight-adjusted fixed-dose low molecular weight heparin for venous thromboembolism.
-
CLINICAL_TRIALS withdrawal · 2021-10-08Clinical Trial Update: Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study [Phase 4]
A Phase 4 randomized trial evaluating enoxaparin versus placebo for preventing venous thromboembolism in low-risk cancer patients after surg…
-
CLINICAL_TRIALS trial_result · 2021-09-10Clinical Trial Update: PREvention of VENous Thromboembolism In Hemorrhagic Stroke Patients [Phase 3]
Phase 3 trial update on prevention of venous thromboembolism in hemorrhagic stroke patients; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs Enoxaparin [Phase 3]
Phase 3 trial comparing rivaroxaban to enoxaparin for venous thromboembolism prophylaxis after gynecologic pelvic cancer surgery.
-
CLINICAL_TRIALS trial_result · 2021-06-10Clinical Trial Update: Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer Patients [Phase 2]
Phase 2 trial comparing weight-based vs standard-dose enoxaparin for venous thromboembolism prevention in high-risk hospitalized cancer pati…
-
CLINICAL_TRIALS trial_result · 2021-05-21Clinical Trial Update: Efficacy of RIvaroxaban for Prevention of Venous Thromboembolism After Knee Arthroscopy [Phase 2]
Phase 2 clinical trial evaluating RIvaroxaban for preventing venous thromboembolism after knee arthroscopy has completed.